About the Authors

Ichiro Maruko

Contributed equally to this work with: Ichiro Maruko, Hideki Koizumi, Taiji Hasegawa, Hisaya Arakawa, Tomohiro Iida

Roles Conceptualization, Data curation, Writing – original draft, Writing – review & editing

imaruko@twmu.ac.jp

Affiliation Department of Ophthalmology, Tokyo Women’s Medical University School of Medicine, Shinjuku, Tokyo, Japan

Hideki Koizumi

Contributed equally to this work with: Ichiro Maruko, Hideki Koizumi, Taiji Hasegawa, Hisaya Arakawa, Tomohiro Iida

Roles Data curation, Writing – review & editing

Affiliation Department of Ophthalmology, Tokyo Women’s Medical University School of Medicine, Shinjuku, Tokyo, Japan

Taiji Hasegawa

Contributed equally to this work with: Ichiro Maruko, Hideki Koizumi, Taiji Hasegawa, Hisaya Arakawa, Tomohiro Iida

Roles Data curation, Writing – review & editing

Affiliation Department of Ophthalmology, Tokyo Women’s Medical University School of Medicine, Shinjuku, Tokyo, Japan

Hisaya Arakawa

Contributed equally to this work with: Ichiro Maruko, Hideki Koizumi, Taiji Hasegawa, Hisaya Arakawa, Tomohiro Iida

Roles Data curation, Writing – review & editing

Affiliation Department of Ophthalmology, Tokyo Women’s Medical University School of Medicine, Shinjuku, Tokyo, Japan

Tomohiro Iida

Contributed equally to this work with: Ichiro Maruko, Hideki Koizumi, Taiji Hasegawa, Hisaya Arakawa, Tomohiro Iida

Roles Supervision, Writing – review & editing

Affiliation Department of Ophthalmology, Tokyo Women’s Medical University School of Medicine, Shinjuku, Tokyo, Japan

Competing Interests

Dr. Maruko reports grants from JSPS KAKENHI (Grant Number JP16K11274), grants and personal fees from Novartis Pharma K.K., personal fees from Bayer Cover Letter Yakuhin, Ltd., personal fees from Santen Pharmaceutical Inc., personal fees from Alcon Japan, Ltd., personal fees from Topcon Co., Ltd., personal fees from Senju Pharmaceutical Co., Ltd., personal fees from NIDEK Co., Ltd., outside the submitted work. Dr. Koizumi reports grants and personal fees from Novartis Pharma K.K., personal fees from Bayer Yakuhin, Ltd., personal fees from Santen Pharmaceutical Inc., personal fees from Alcon Japan, Ltd., personal fees from Topcon Co., Ltd., personal fees from Senju Pharmaceutical Co., Ltd., personal fees from HOYA Corp., personal fees from Canon Inc., personal fees from Wakamoto Pharmaceutical Co., Ltd., personal fees from NIDEK Co., Ltd., outside the submitted work;. Dr. Hasegawa has nothing to disclose. Dr. Arakawa has nothing to disclose. Dr. Iida reports grants and personal fees from Novartis Pharma K.K. (Japan), personal fees from Bayer Yakuhin, Ltd. (Japan), grants and personal fees from Santen Pharmaceutical Co., Ltd. (japan), grants from Nidek, research support from Chuosangyo (Japan), outside the submitted work;. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.